Isolation of Carbapenem and Colistin Resistant Gram-Negative Bacteria Colonizing Immunocompromised SARS-CoV-2 Patients Admitted to Some Libyan Hospitals.
COVID-19
Libya
SARS-CoV-2
bacteria
carbapenemase
colistin resistance
colonization
infection
Journal
Microbiology spectrum
ISSN: 2165-0497
Titre abrégé: Microbiol Spectr
Pays: United States
ID NLM: 101634614
Informations de publication
Date de publication:
15 06 2023
15 06 2023
Historique:
medline:
19
6
2023
pubmed:
13
4
2023
entrez:
12
4
2023
Statut:
ppublish
Résumé
The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has had a devastating effect, globally. We describe, for the first time, the occurrence of carbapenem-resistant bacteria colonizing SARS-CoV-2 patients who developed hospital-associated infections with carbapenemase-producing, Gram-negative bacteria at some isolation centers of SARS-CoV-2 in the eastern part of Libya. In total, at first, 109 samples were collected from 43 patients, with the samples being recovered from oral (
Identifiants
pubmed: 37042782
doi: 10.1128/spectrum.02972-22
pmc: PMC10269485
doi:
Substances chimiques
Colistin
Z67X93HJG1
Carbapenems
0
Anti-Bacterial Agents
0
beta-Lactamases
EC 3.5.2.6
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0297222Déclaration de conflit d'intérêts
The authors declare no conflict of interest.
Références
BMC Microbiol. 2017 Nov 23;17(1):220
pubmed: 29169321
J Glob Antimicrob Resist. 2017 Sep;10:88-94
pubmed: 28711559
Clin Infect Dis. 2005 May 1;40(9):1333-41
pubmed: 15825037
Infection. 2022 Feb;50(1):83-92
pubmed: 34176088
Int J Antimicrob Agents. 2013 Sep;42(3):268-71
pubmed: 23880169
IUBMB Life. 2011 Dec;63(12):1061-7
pubmed: 21990280
PLoS One. 2021 May 11;16(5):e0251340
pubmed: 33974637
Infect Drug Resist. 2018 Sep 12;11:1447-1460
pubmed: 30254476
Antimicrob Resist Infect Control. 2020 Sep 22;9(1):153
pubmed: 32962731
Microb Genom. 2019 Oct;5(10):
pubmed: 31599224
Appl Environ Microbiol. 2019 Jun 17;85(13):
pubmed: 31028024
Am J Infect Control. 2020 Dec;48(12):1533-1536
pubmed: 33011336
Emerg Infect Dis. 2020 Jul;26(7):1592-1595
pubmed: 32284092
J Antimicrob Chemother. 2016 May;71(5):1135-47
pubmed: 26755496
Pathogens. 2020 Jan 31;9(2):
pubmed: 32024012
Bioinformatics. 2015 Aug 15;31(16):2745-7
pubmed: 25851949
J Med Microbiol. 2013 Sep;62(Pt 9):1332-1337
pubmed: 23741025
Antimicrob Resist Infect Control. 2019 Oct 29;8:167
pubmed: 31687131
Am J Infect Control. 2021 Oct;49(10):1324-1326
pubmed: 34273465
Antibiotics (Basel). 2021 Sep 18;10(9):
pubmed: 34572709
Int J Infect Dis. 2021 Mar;104:250-254
pubmed: 33434666
J Infect. 2020 Aug;81(2):266-275
pubmed: 32473235
Viruses. 2021 Jan 29;13(2):
pubmed: 33572857
Int J Infect Dis. 2017 Jan;54:77-84
pubmed: 27915108
J Glob Antimicrob Resist. 2021 Mar;24:27-28
pubmed: 33279684
J Glob Antimicrob Resist. 2019 Dec;19:356-357
pubmed: 31707220
EMBO Mol Med. 2020 Jul 7;12(7):e12560
pubmed: 32453917
Rev Esp Quimioter. 2020 Dec;33(6):448-452
pubmed: 33059423
Clin Microbiol Infect. 2020 Dec;26(12):1622-1629
pubmed: 32711058
Int J Environ Res Public Health. 2021 Jan 23;18(3):
pubmed: 33498701
Int J Antimicrob Agents. 2021 Jan;57(1):106245
pubmed: 33253903
J Antimicrob Chemother. 2015 Nov;70(11):2987-91
pubmed: 26260129
Infect Drug Resist. 2020 Oct 05;13:3409-3422
pubmed: 33116660
Antimicrob Agents Chemother. 2015 Aug;59(8):5073-7
pubmed: 26055374
Environ Microbiol. 2020 Jul;22(7):2469-2484
pubmed: 32114703
Pathogens. 2021 Mar 24;10(4):
pubmed: 33804894
Lancet Infect Dis. 2016 Feb;16(2):161-8
pubmed: 26603172
Int J Antimicrob Agents. 2016 Dec;48(6):583-591
pubmed: 27524102
J Glob Antimicrob Resist. 2017 Jun;9:15-16
pubmed: 28286141